Article Sidebar

pdf
Date Published: 19/09/2025
Abstract Views: 122
Views pdf: 42
DOI: https://doi.org/10.51298/vmj.v553i3.15458
Issue
Vol. 553 No. 3 (2025)
Section
Các bài báo
How to Cite
Trần, D. H., Nguyễn, T. H., Lê, T. S., & Bùi, K. C. (2025). STUDY ON THE RELATIONSHIP BETWEEN PLASMA ADIPONECTIN LEVELS AND SOME HEMATOLOGICAL PARAMETERS IN PATIENTS WITH GASTRIC CARCINOMA. Vietnam Medical Journal, 553(3). https://doi.org/10.51298/vmj.v553i3.15458

STUDY ON THE RELATIONSHIP BETWEEN PLASMA ADIPONECTIN LEVELS AND SOME HEMATOLOGICAL PARAMETERS IN PATIENTS WITH GASTRIC CARCINOMA

Doanh Hiệu Trần, Trọng Hòe Nguyễn, Thanh Sơn Lê, Khắc Cường Bùi

Main Article Content

Abstract

Objectives: To investigate the association between plasma adiponectin levels and some hematological characteristics in gastric carcinoma patients. Subjects and methods: This descriptive longitudinal study was conducted on 68 patients with histologically confirmed gastric carcinoma who underwent curative gastrectomy. Preoperative serum adiponectin levels were measured using a sandwich ELISA (FineTest). Hematological parameters were compared between two groups classified according to the median adiponectin value. Results: The low adiponectin group had significantly higher lymphocyte counts (p = 0.011), red blood cell counts (p = 0.009), and hematocrit levels (p = 0.021). Anemia was more common in the high adiponectin group (p = 0.013). No significant differences were found in neutrophil or platelet counts. Conclusion: Patients with gastric cancer who have low adiponectin levels exhibit higher lymphocyte counts, red blood cell counts, and hematocrit values; conversely, those with high adiponectin levels are more prone to anemia than the low-adiponectin group

Article Details

Keywords

Gastric carcinoma; adiponectin; hematological indices; systemic inflammation

References

Bray F., Laversanne M., Sung H., et al. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 74(3): 229-263.
2. Tan S., Zheng Q., Zhang W., et al. (2024). Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review. Front Immunol, 15: 1408700.
3. Ming C., Orita H., Yan S., et al. (2023). The role of adiponectin in gastric cancer. Journal of Cancer Metastasis and Treatment, 9.
4. World Health O. (2013). International classification of diseases for oncology (‎ICD-O)‎ – 3rd edition, 1st revision, 3rd ed., Geneva.
5. Japanese Gastric Cancer A. (2020). Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer.
6. Kordafshari M., Nourian M., Mehrvar N., et al. (2020). Expression of AdipoR1 and AdipoR2 and Serum Level of Adiponectin in Gastric Cancer. Gastrointestinal tumors, 7(4): 103-109.
7. Ehling A., Schäffler A., Herfarth H., et al. (2006). The potential of adiponectin in driving arthritis. J Immunol, 176(7): 4468-4478.
8. Lewerin C., Johansson H., Lerner U. H., et al. (2015). High serum adiponectin is associated with low blood haemoglobin in elderly men: the Swedish MrOS study. Journal of internal medicine, 278(1): 68-76.
9. Kerem M., Ferahkose Z., Yilmaz U. T., et al. (2008). Adipokines and ghrelin in gastric cancer cachexia. World J Gastroenterol, 14(23): 3633-3641.
10. Batista M. L., Olivan M., Alcantara P. S. M., et al. (2013). Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine, 61(2): 532-539.